the ability of ligand occupation and removal of hydrolysis products to attenuate the effects of pla2-treatment on muscarinic receptor sites may be explained if modification of the membrane lipid bilayer leads to transitions between different states of the receptor .
C0020291
hydrolysis
C0031667
pla2